Improving drug-like properties of insulin and GLP-1 via molecule design and formulation and improving diabetes management with device & drug delivery.
第一作者:
Sergei,Pechenov
第一单位:
MedImmune, One MedImmune Way, Gaithersburg, MD 20878, USA. Electronic address: pechenovs@medimmune.com.
作者:
主题词
动物(Animals);糖尿病, 2型(Diabetes Mellitus, Type 2);药物调剂(Drug Compounding);药物释放系统(Drug Delivery Systems);药物设计(Drug Design);胰高血糖素样肽1(Glucagon-Like Peptide 1);人类(Humans);降血糖药(Hypoglycemic Agents);胰岛素(Insulin)
DOI
10.1016/j.addr.2017.01.006
PMID
28153578
发布时间
2018-12-02
- 浏览6
Advanced drug delivery reviews
106-122页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文